Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)

Background: Fourth-line therapy (4LT) in the treatment of metastatic renal cell carcinoma (mRCC) varies significantly due to the lack of data and recommendations to guide treatment decisions. Objective: To evaluate the use and efficacy of 4LT in mRCC patients. Methods: The International mRCC Databas...

Descrición completa

Detalles Bibliográficos

Principais autores:	Igor Stukalin, J. Connor Wells, Anna Fraccon, Felice Pasini, Camillo Porta, Aly-Khan A. Lalani, Sandy Srinivas, I. Alex Bowman, James Brugarolas, Jae-Lyun Lee, Frede Donskov, Benoit Beuselinck, Aristotelis Bamias, Brian I. Rini, Hao-Wen Sim, Neeraj Agarwal, Sun-Young Rha, Ravindran Kanesvaran, Toni K. Choueiri, Daniel Y.C. Heng
Formato:	Artigo
Idioma:	Inglês
Publicado:	SAGE Publishing 2018-03-01
Series:	Kidney Cancer
Acceso en liña:	https://doi.org/10.3233/KCA-170020
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!